Showing results (351-360 of 386) with videos related to

Sort By:
Pageof 39
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
Genome Medicine|January 26, 2023
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestryStefanie H Mueller, Alvina G Lai, Maria Valkovskaya, et al.
American Journal of Human Genetics|June 19, 2021
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer elementJoseph S Baxter, Nichola Johnson, Katarzyna Tomczyk, et al.
Breast Cancer Research : BCR|April 29, 2015
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersKaroline B Kuchenbaecker, Susan L Neuhausen, Mark Robson, et al.
American Journal of Human Genetics|December 3, 2013
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1Kerstin B Meyer, Martin O'Reilly, Kyriaki Michailidou, et al.
Plos Genetics|April 5, 2014
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L Milne, Karoline Kuchenbaecker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R Barnes, Matti A Rookus, Lesley McGuffog, et al.
Breast Cancer Research : BCR|May 1, 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Claire Bardel, Vincent Danjean, et al.
Breast Cancer Research : BCR|April 11, 2015
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortiaAmanda B Spurdle, Fergus J Couch, Michael T Parsons, et al.
Pageof 39